Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Pain Resilience and Pain Self-Efficacy as Parallel Mediators of the Relationship Between Self-Critical Rumination and Pain-Specific Well-Being in Individuals With Chronic Pain: A Structural Equation Modeling Study

22 de setembro de 2026 atualizado por: Semanur Bilgiç, Bilecik Seyh Edebali Universitesi

This study is a cross-sectional, correlational, and analytical study designed to examine the parallel mediating roles of pain resilience and pain self-efficacy in the relationship between self-critical rumination and pain-specific well-being in individuals with chronic pain. Structural equation modeling will be used to simultaneously evaluate the direct and indirect relationships between the variables.

Visão geral do estudo

Status

Ainda não está recrutando

Condições

Descrição detalhada

Chronic pain is a multidimensional health issue that affects not only an individual's physical functioning but also their psychological adjustment and well-being. It is posited that negative cognitive patterns-such as self-critical rumination-can adversely affect an individual's pain experience and well-being, whereas psychological resources-such as pain resilience and pain self-efficacy-may play a significant role in mitigating these effects. This study was designed to examine the parallel mediating roles of pain resilience and pain self-efficacy in the relationship between self-critical rumination and pain-specific well-being in individuals with chronic pain.

Tipo de estudo

Observacional

Inscrição (Estimado)

451

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Contato de estudo

Locais de estudo

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

18 anos e mais velhos (Adulto, Adulto mais velho)

Aceita Voluntários Saudáveis

Não

Gêneros Elegíveis para o Estudo

Tudo

Método de amostragem

Amostra Não Probabilística

População do estudo

Having chronic pain that has persisted or recurred for at least three months

Descrição

Inclusion Criteria:

  • Individuals aged 18 years and older,
  • Having chronic pain that has persisted or recurred for at least three months,
  • Being followed up for chronic pain at the Physical Therapy and Rehabilitation Outpatient Clinic,
  • Able to read and understand Turkish and communicate at a level sufficient to complete data collection forms,
  • And agreeing to participate in the research voluntarily will be included.

Exclusion Criteria:

  • Individuals with pain lasting less than three months or experiencing only acute pain,
  • Individuals with cancer-related pain,
  • Individuals in the palliative or terminal stage,
  • Individuals who have undergone major surgery within the last three months and still experience acute/postoperative pain related to the surgery,
  • Individuals with cognitive or communication impairments that would prevent them from understanding the research questions and independently responding to the data collection instruments will be excluded.

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Modelos de observação: OTHER
  • Perspectivas de Tempo: CROSS_SECTIONAL

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Numerical Rating Scales
Prazo: 1 days

Numerical Rating Scales (NRS): In alignment with the IASP Classification of Chronic Pain for the International Classification of Diseases (ICD-11), participants' pain intensity over the past week, the impact of pain on daily activities, and the level of pain-related distress will be assessed separately using 0-10 numerical rating scales. Pain intensity will be rated from 0 ("no pain") to 10 ("worst pain imaginable"); the impact of pain on daily life from 0 ("no impact") to 10 ("completely prevents my activities"); and pain-related distress from 0 ("no distress") to 10 ("extreme distress").

1 days
The University of Washington Pain-Related Self-Efficacy Scale-Short Form
Prazo: 1 days

The University of Washington Pain-Related Self-Efficacy Scale-Short Form is a 6-item scale developed to assess patients' perceptions regarding their self-efficacy-or confidence-in performing daily, social, and personal activities despite pain. Each item is rated on a 5-point Likert-type scale ranging from 1 ("not at all confident") to 5 ("completely confident"). Total scores on the scale range from 6 to 30, with higher scores indicating a higher level of pain-related self-efficacy. The Cronbach's alpha value was reported as 0.87 in the study regarding the Turkish validity and reliability of the scale.

1 days
Well-Being in Pain Questionnaire
Prazo: 1 days

This scale was developed to assess well-being in the presence of pain among individuals with chronic pain, as well as the psychological, social, and lifestyle-related characteristics that support such well-being. The scale consists of a total of 11 items rated on a 5-point Likert scale ranging from 0 ("never") to 4 ("almost always"). The total score is calculated by summing the responses to all items and ranges from 0 to 44. Higher scores indicate a higher level of pain-related well-being; a score of 0 represents the minimum level, while a score of 44 represents the maximum level of pain-related well-being. In the study regarding the Turkish validity and reliability of the scale, the Cronbach's alpha value was reported as 0.713.

1 days
Self-Critical Rumination Scale
Prazo: 1 days

Self-Critical Rumination Scale: Developed by Smart et al. (2016) to assess ruminative processes associated with self-critical thoughts, this scale consists of 10 items. Respondents rate how well the statements describe them using a 4-point Likert-type scale (1 = does not describe at all, 2 = describes very little, 3 = describes moderately, 4 = describes very well). In the original study examining its psychometric properties, the scale's internal consistency coefficient was found to be .92, and it was determined to have a single-factor structure. It was also reported that the scale shows high correlations with constructs related to both self-criticism and rumination. In the study regarding the Turkish validity and reliability of the scale, the Cronbach's alpha value was reported as 0.89.

1 days
Pain Resilience Scale
Prazo: 1 days

Pain Resilience Scale: This is a 14-item scale that assesses the cognitive, emotional, and behavioral responses individuals exhibit when facing intense or prolonged pain. The scale comprises two sub-dimensions: behavioral persistence (items 1-5) and a positive cognitive-emotional approach (items 6-14). Items are scored on a scale ranging from 0 ("never") to 4 ("always"). In the Turkish version of the PRS, only items 8, 11, and 12 are reverse-scored; for these items, the scoring is reversed from 4 ("always") to 0 ("never"). A high total score on the scale indicates a high level of pain resilience. The Cronbach's alpha value was reported as 0.920 in the study establishing the scale's validity and reliability in Turkish.

1 days

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Estimado)

31 de outubro de 2026

Conclusão Primária (Estimado)

30 de junho de 2027

Conclusão do estudo (Estimado)

1 de dezembro de 2027

Datas de inscrição no estudo

Enviado pela primeira vez

16 de setembro de 2026

Enviado pela primeira vez que atendeu aos critérios de CQ

22 de setembro de 2026

Primeira postagem (Real)

29 de setembro de 2026

Atualizações de registro de estudo

Última Atualização Postada (Real)

29 de setembro de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

22 de setembro de 2026

Última verificação

1 de setembro de 2026

Mais Informações

Termos relacionados a este estudo

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever